Literature DB >> 687517

Assessment of response to therapy in advanced breast cancer (an amendment)

J L Hayward, P P Carbone, R D Rubens, J C Heuson, S Kumaoka, A Segaloff.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 687517      PMCID： PMC2009675          DOI： 10.1038/bjc.1978.182

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.

Authors:  Maurice P H M Jansen; Leen Sas; Anieta M Sieuwerts; Caroline Van Cauwenberghe; Diana Ramirez-Ardila; Maxime Look; Kirsten Ruigrok-Ritstier; Pascal Finetti; François Bertucci; Mieke M Timmermans; Carolien H M van Deurzen; John W M Martens; Iris Simon; Paul Roepman; Sabine C Linn; Peter van Dam; Marleen Kok; Filip Lardon; Peter B Vermeulen; John A Foekens; Luc Dirix; Els M J J Berns; Steven Van Laere
Journal:  Mol Oncol       Date:  2015-03-04       Impact factor: 6.603

2.  Radiographic evaluation of therapeutic response in bony metastases of breast cancer.

Authors:  H I Libshitz; G N Hortobagyi
Journal:  Skeletal Radiol       Date:  1981       Impact factor: 2.199

Review 3.  Imaging response to systemic therapy for bone metastases.

Authors:  Tobias Bäuerle; Wolfhard Semmler
Journal:  Eur Radiol       Date:  2009-05-26       Impact factor: 5.315

4.  A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone.

Authors:  Kuei C Lee; Deborah A Bradley; Maha Hussain; Charles R Meyer; Thomas L Chenevert; Jon A Jacobson; Timothy D Johnson; Craig J Galban; Alnawaz Rehemtulla; Kenneth J Pienta; Brian D Ross
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

5.  Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.

Authors:  H Gabra; D A Cameron; L E Lee; J Mackay; R C Leonard
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

Review 6.  Bone metastases in thyroid cancer.

Authors:  Nicole M Iñiguez-Ariza; Keith C Bible; Bart L Clarke
Journal:  J Bone Oncol       Date:  2020-02-19       Impact factor: 4.072

7.  Clinical performance evaluation of O-Ring Halcyon Linac: A real-world study.

Authors:  Guang-Yu Wang; Qi-Zhen Zhu; He-Ling Zhu; Ling-Juan Jiang; Nan Zhao; Zhi-Kai Liu; Fu-Quan Zhang
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

8.  Chemotherapy of advanced breast cancer: outcome and prognostic factors.

Authors:  W M Gregory; P Smith; M A Richards; C J Twelves; R K Knight; R D Rubens
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

9.  Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.

Authors:  Tommaso De Marchi; Anne M Timmermans; Marcel Smid; Maxime P Look; Christoph Stingl; Mark Opdam; Sabine C Linn; Fred C G J Sweep; Paul N Span; Mike Kliffen; Carolien H M van Deurzen; Theo M Luider; John A Foekens; John W Martens; Arzu Umar
Journal:  Oncotarget       Date:  2016-01-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.